Suppr超能文献

TIM-3、LAG-3 和 TIGIT。

Tim-3, Lag-3, and TIGIT.

机构信息

Institute for Experimental Immunology, University of Zurich, Zurich, Switzerland.

Harvard Medical School and Brigham & Women's Hospital, Evergrande Center for Immunologic Diseases, Boston, MA, USA.

出版信息

Curr Top Microbiol Immunol. 2017;410:127-156. doi: 10.1007/82_2017_62.

Abstract

Co-inhibitory receptors play a key role in regulating T cell responses and maintaining immune homeostasis. Their inhibitory function prevents autoimmune responses but also restricts the ability of T cells to mount effective immune responses against tumors or persistent pathogens. T cells express a module of co-inhibitory receptors, which display great diversity in expression, structure, and function. Here, we focus on the co-inhibitory receptors Tim-3, Lag-3, and TIGIT and how they regulate T cell function, maintenance of self-tolerance, their role in regulating ongoing T cell responses at peripheral tissues, and their synergistic effects in regulating autoimmunity and antitumor responses.

摘要

抑制性受体在调节 T 细胞反应和维持免疫稳态方面发挥着关键作用。它们的抑制功能可以防止自身免疫反应,但也限制了 T 细胞对肿瘤或持续性病原体产生有效免疫反应的能力。T 细胞表达一系列抑制性受体,这些受体在表达、结构和功能上具有很大的多样性。在这里,我们重点介绍 Tim-3、Lag-3 和 TIGIT 这三种抑制性受体,以及它们如何调节 T 细胞功能、维持自身耐受、在调节外周组织中持续的 T 细胞反应中的作用,以及它们在调节自身免疫和抗肿瘤反应中的协同作用。

相似文献

1
Tim-3, Lag-3, and TIGIT.TIM-3、LAG-3 和 TIGIT。
Curr Top Microbiol Immunol. 2017;410:127-156. doi: 10.1007/82_2017_62.

引用本文的文献

本文引用的文献

4
Targeting T Cell Co-receptors for Cancer Therapy.靶向 T 细胞共受体进行癌症治疗。
Immunity. 2016 May 17;44(5):1069-78. doi: 10.1016/j.immuni.2016.04.023.
5
CD28 Costimulation: From Mechanism to Therapy.CD28共刺激:从机制到治疗
Immunity. 2016 May 17;44(5):973-88. doi: 10.1016/j.immuni.2016.04.020.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验